Generic-drug makers including Momenta Pharmaceuticals Inc. urged the U.S. Supreme Court to let them introduce generic versions of Teva Pharmaceutical Industries Ltd.’s Copaxone multiple-sclerosis drug next month.
A U.S. Supreme Court justice asked generic-drug makers to respond to Teva Pharmaceutical Industries Ltd.’s bid for perhaps a yearlong delay on competition to its top-selling Copaxone multiple-sclerosis drug.
A divided U.S. Supreme Court struck down decades-old limits on the total amount donors can give to federal candidates and parties, dealing a fresh blow to efforts to curb the role of money in American politics.
The U.S. Supreme Court agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. in a move that may delay generic competition to the company’s top-selling Copaxone multiple-sclerosis drug and alter how patent appeals are handled. Teva rose on the news.
U.S. Supreme Court justices signaled they will bolster the Secret Service’s legal immunity as they weighed a bid to sue agents for allegedly shielding President George W. Bush from protesters a decade ago.
With a single vote supporting President Barack Obama’s health-care law, Republican-appointed Chief Justice John Roberts asserted his independence and defused claims that partisanship rules the Supreme Court.